Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Evidence for cyclic diguanylate as a vaccine adjuvant with novel immunostimulatory activities.

Gray PM, Forrest G, Wisniewski T, Porter G, Freed DC, DeMartino JA, Zaller DM, Guo Z, Leone J, Fu TM, Vora KA.

Cell Immunol. 2012 Jul-Aug;278(1-2):113-9. doi: 10.1016/j.cellimm.2012.07.006. Epub 2012 Aug 4.

PMID:
23121983
2.

c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infection.

Hu DL, Narita K, Hyodo M, Hayakawa Y, Nakane A, Karaolis DK.

Vaccine. 2009 Jul 30;27(35):4867-73. doi: 10.1016/j.vaccine.2009.04.053. Epub 2009 May 9.

PMID:
19406185
3.

CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen.

Davis HL, Weeratna R, Waldschmidt TJ, Tygrett L, Schorr J, Krieg AM.

J Immunol. 1998 Jan 15;160(2):870-6. Erratum in: J Immunol 1999 Mar 1;162(5):3103. Weeranta R [corrected to Weeratna R].

4.

Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen.

Mutwiri G, Benjamin P, Soita H, Babiuk LA.

Vaccine. 2008 May 23;26(22):2680-8. doi: 10.1016/j.vaccine.2008.03.031. Epub 2008 Apr 3.

PMID:
18430493
5.

Synthetic innate defense regulator peptide combination using CpG ODN as a novel adjuvant induces long‑lasting and balanced immune responses.

Yu CH, Luo ZC, Li M, Lu L, Li Z, Wu XZ, Fan YZ, Zhang HL, Zhou BL, Wan Y, Men K, Tian YM, Chen S, Yuan FJ, Xiang R, Yang L.

Mol Med Rep. 2016 Jan;13(1):915-24. doi: 10.3892/mmr.2015.4581. Epub 2015 Nov 19.

PMID:
26647852
6.

Vaccination with novel immunostimulatory adjuvants against blood-stage malaria in mice.

Su Z, Tam MF, Jankovic D, Stevenson MM.

Infect Immun. 2003 Sep;71(9):5178-87.

7.

Bacterial c-di-GMP is an immunostimulatory molecule.

Karaolis DK, Means TK, Yang D, Takahashi M, Yoshimura T, Muraille E, Philpott D, Schroeder JT, Hyodo M, Hayakawa Y, Talbot BG, Brouillette E, Malouin F.

J Immunol. 2007 Feb 15;178(4):2171-81.

8.

Effects of different adjuvants in the context of intramuscular and intranasal routes on humoral and cellular immune responses induced by detergent-split A/H3N2 influenza vaccines in mice.

Baz M, Samant M, Zekki H, Tribout-Jover P, Plante M, Lanteigne AM, Hamelin ME, Mallett C, Papadopoulou B, Boivin G.

Clin Vaccine Immunol. 2012 Feb;19(2):209-18. doi: 10.1128/CVI.05441-11. Epub 2011 Dec 21.

9.

c-di-GMP is an effective immunomodulator and vaccine adjuvant against pneumococcal infection.

Ogunniyi AD, Paton JC, Kirby AC, McCullers JA, Cook J, Hyodo M, Hayakawa Y, Karaolis DK.

Vaccine. 2008 Aug 26;26(36):4676-85. doi: 10.1016/j.vaccine.2008.06.099. Epub 2008 Jul 18.

10.

CpG-DNA stimulates cellular and humoral immunity and promotes Th1 differentiation in aged BALB/c mice.

Maletto B, Rópolo A, Morón V, Pistoresi-Palencia MC.

J Leukoc Biol. 2002 Sep;72(3):447-54.

PMID:
12223511
11.

A study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine.

Svindland SC, Pedersen GK, Pathirana RD, Bredholt G, Nøstbakken JK, Jul-Larsen Å, Guzmán CA, Montomoli E, Lapini G, Piccirella S, Jabbal-Gill I, Hinchcliffe M, Cox RJ.

Influenza Other Respir Viruses. 2013 Nov;7(6):1181-93. doi: 10.1111/irv.12056. Epub 2012 Nov 21.

12.

An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal mice.

Khalil SM, Tonkin DR, Snead AT, Parks GD, Johnston RE, White LJ.

J Virol. 2014 Aug;88(16):9182-96. doi: 10.1128/JVI.00327-14. Epub 2014 Jun 4.

13.

Comparison of the immune responses to the CIA06-adjuvanted human papillomavirus L1 VLP vaccine with those against the licensed HPV vaccine Cervarix™ in mice.

Han JE, Wui SR, Park SA, Lee NG, Kim KS, Cho YJ, Kim HJ, Kim HJ.

Vaccine. 2012 Jun 13;30(28):4127-34. doi: 10.1016/j.vaccine.2012.04.079. Epub 2012 May 1.

PMID:
22561312
14.

Intranasal c-di-GMP-adjuvanted plant-derived H5 influenza vaccine induces multifunctional Th1 CD4+ cells and strong mucosal and systemic antibody responses in mice.

Madhun AS, Haaheim LR, Nøstbakken JK, Ebensen T, Chichester J, Yusibov V, Guzman CA, Cox RJ.

Vaccine. 2011 Jul 12;29(31):4973-82. doi: 10.1016/j.vaccine.2011.04.094. Epub 2011 May 18.

PMID:
21600260
15.
16.

CpG oligonucleotide, host defense peptide and polyphosphazene act synergistically, inducing long-lasting, balanced immune responses in cattle.

Kovacs-Nolan J, Mapletoft JW, Latimer L, Babiuk LA, Hurk Sv.

Vaccine. 2009 Mar 23;27(14):2048-54. doi: 10.1016/j.vaccine.2009.01.117. Epub 2009 Feb 2.

PMID:
19428829
17.

CpG-containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpesvirus glycoprotein.

Ioannou XP, Gomis SM, Karvonen B, Hecker R, Babiuk LA, van Drunen Littel-van den Hurk S.

Vaccine. 2002 Nov 22;21(1-2):127-37.

PMID:
12443671
18.
19.

Three CpG oligodeoxynucleotide classes differentially enhance antigen-specific humoral and cellular immune responses in mice.

Liu Y, Luo X, Yang C, Yu S, Xu H.

Vaccine. 2011 Aug 5;29(34):5778-84. doi: 10.1016/j.vaccine.2011.05.087. Epub 2011 Jun 12.

PMID:
21664398
20.

Supplemental Content

Support Center